AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Compugen Ltd. will participate in a fireside chat at the Stifel 2025 Healthcare Conference in New York City on November 11, 2025. The company's management will discuss its clinical-stage cancer immunotherapy products, including COM701, a potential first-in-class immunotherapy candidate. A live webcast will be available on the Compugen website, and a replay will also be available after the event.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet